What Happened to GE HealthCare Technologies Inc.?

GE HealthCare Technologies Inc. has a rich history rooted in the Victor Electric Company, founded in 1893, which was acquired by General Electric in 1920, marking GE's entry into the imaging technology business. For decades, it operated as a key division within the GE conglomerate, diversifying into various medical technology businesses and investing heavily in R&D.

The most significant turning point for GE HealthCare occurred on November 9, 2021, when General Electric announced its plan to split into three independent, publicly traded companies: GE HealthCare, GE Vernova, and GE Aerospace. This strategic move aimed to unlock value by allowing each entity to focus on its core growth sectors. The spin-off of GE HealthCare was completed on January 3, 2023, with the company beginning regular trading on Nasdaq under the ticker 'GEHC' the following day. GE shareholders received one GE HealthCare share for every three GE shares held.

Since becoming independent, GE HealthCare has sharpened its focus on 'precision care,' integrating smart devices, pharmaceuticals, AI, and cloud solutions across disease states. The company operates through four primary segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. In 2025, the company reported full-year revenues of $20.6 billion. A key strategic move was the announcement in November 2025 of its agreement to acquire Intelerad, a leading medical imaging software provider, for $2.3 billion. This acquisition, completed in March 2026, significantly expanded GE HealthCare's cloud-enabled enterprise imaging footprint, particularly in outpatient and ambulatory care settings, and is expected to increase its recurring revenue mix.

In 2026, GE HealthCare continued to demonstrate business momentum. In April 2026, the company announced strategic operational updates, combining its Imaging and Advanced Visualization Solutions (AVS) segments into a new, larger segment called Advanced Imaging Solutions (AIS), to create a more focused and connected end-to-end imaging ecosystem. The company reported strong second-quarter 2026 financial results on July 29, 2026, with revenues of $5.3 billion, up 5.7% year-over-year, and organic revenue growth of 3.5%. The quarter also saw record organic orders growth of 11.1% and a backlog of $23.9 billion. However, its Patient Care Solutions (PCS) segment continued to face challenges.

Leadership also saw changes in 2026, with James (Jay) Saccaro stepping down as Chief Financial Officer in July, and George Newcomb appointed as interim CFO. The company also launched its new LOGIQ e family of AI-enabled laptop ultrasound systems in August 2026, reinforcing its push into portable, AI-assisted point-of-care imaging. As of August 23, 2026, GE HealthCare has a market capitalization of approximately $33-34 billion, and analysts project continued sales growth driven by new products and strategic investments.